Mainz Biomed BV (MYNZ) — Strategic Asset Allocation Index
Mainz Biomed BV (MYNZ) has a Strategic Asset Allocation Index of 3.4% as of June 2022. Strategic assets (PP&E of $805.51K plus long-term investments of $-) total $805.51K, measured against net assets of $23.77 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Mainz Biomed BV Strategic Asset Allocation Index (2021–2021)
This chart shows how Mainz Biomed BV's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2022, the index stands at 3.4%, representing strategic assets of $805.51K against net assets of $23.77 Million USD. Explore cash efficiency ratio of Mainz Biomed BV to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Mainz Biomed BV (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Mainz Biomed BV from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Mainz Biomed BV stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 6.8% | $431.59K | $431.59K | $- | $6.36 Million | — |